Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2008-04-11
2010-06-08
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S141100, C424S143100, C424S144100, C424S173100, C435S007100, C435S334000, C435S343000, C435S346000, C530S387100, C530S388100, C530S388220, C530S388700
Reexamination Certificate
active
07731966
ABSTRACT:
Monoclonal antibodies prepared against platelet β3integrin useful in antithrombotic therapy or in models of thrombosis, thrombocytopenia, and anti-angiogenesis. The antibodies are prepared using β3integrin deficient (β3−/−) mice immunized against platelets or β3integrin fragments.
REFERENCES:
patent: 5766591 (1998-06-01), Brooks et al.
patent: 6951645 (2005-10-01), Ruan et al.
patent: WO01/21196 (2001-03-01), None
European Patent Office Extended European Search Report corresponding to European Patent Application No. 08153880.3-2402 dated Aug. 8, 2008.
International Search Report corresponding to International Application No. PCT/US00/26095 dated Jan. 9, 2001.
Mould, Paul A., et al., Evidence that monoclonal antibodies directed against the integrin beta subunit plexin/semaphorin/integrin domain stimulate function by inducing receptor extension.The Journal of Biological Chemistry. vol. 280, No. 6. pp. 4238-4246. (Feb. 2005).
Ni, H., et al., lntegrin activation by dithiothreitol or Mn2+ induces a ligand-occupied conformation and exposure of a novel NH2-terminal regulatory site on the beta1 integrin chain.The Journal of Biological Chemistry. vol. 273, No. 14. pp. 7981-7987. (Apr. 1998).
Peterson, Julie A., et al., A site involving the “hybrid” and PSI homology domains of GPIIIa (beta 3-integrin subunit) is a common target for antibodies associated with quinine-induced immune thrombocytopenia.Blood. vol. 101, No. 3. pp. 937-942. (Feb. 2003).
Xiao, Tsan, et al., Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics.Nature. vol. 432, No. 7013. pp. 59-67. (Nov. 2004).
Zhu, Guangheng, et al., Novel mouse anti-mouse beta 3 integrin monoclonal antibodies: Development, and characterization of new reagents for research in thrombosis and thrombocytopenia.Blood. vol. 110, No. 11. p. 627A. (Nov. 2007).
Beglova et al.,Cysteine-Rich Module Structure Reveals a Fulcrum for Integrin Rearrangement upon Activation. Nature Structural Biology. vol. 9, No. 4 pp. 282-287 (2002).
Behan, M.W.H and Storey, R.F.,Antiplatelet Therapy in Cardiovascular Disease. Postgrad. Med. J. vol. 80, pp. 155-164 (2004).
Bennett,Structure and Function of the Platelet Integrin αIIbβ3. The Journal of Clinical Investigation. vol. 115, No. 12 pp. 3363-3369 (2005).
Calvete, Juan,Minireview - Platelet Integrin GPIlb/Illa: Structure-Function Correlations. An Update and Lessons from Other Integrins. Platelet Integrin GPIIB/IIIA. pp. 29-38 (update to previously published paper in Proc. Soc. Exp. Biol. Med. 208:346-360, 1995).
Cluzel et al.,The Mechanisms and Dynamics of avβ3 Integrin Clustering in Living Cells. Journal of Cell Biology. vol. 171 pp. 383-392 (2005).
Filizola et al.,Mechanistic Insights from a Refined Three-Dimensional Model of Integrin αIIbβ3. The Journal of Biological Chemistry. vol. 279, No. 23 pp. 24624-24630 (2004).
Litvinov et al.,Multi-Step Fibrinogen Binding to the Integrin αIIbβ3Detected Using Force Spectroscopy. Biophysical Journal. vol. 89 pp. 2824-2834 (2005).
Ni et al.,A Novel Murine Model of Fetal and Neonatal Alloimmune Thrombocytopenia: Response to Intravenous IgG Therapy. Blood. vol. 107, No. 7 pp. 2976-2983 (2006).
Ni et al.,Persistence of Platelet Thrombus Formation in Arterioles of Mice Lacking Both von Willebrand Factor and Fibrinogen. The Journal of Clinical Investigation. vol. 106, No. 3 pp. 385-392 (2000).
Webster et al.,Relative efficacy of intravenous immunoglobin G in ameliorating thrombocytopenia induced by antiplatelet GPlIbIlla versus GPlbα antibodies. Blood. vol. 108, No. 3 pp. 943-946 (2006).
Yang et al.,Fibrinogen and von Willebrand Factor-Independent Platelet Aggregation In Vitro and In Vivo. Journal of Thrombosis and Haemostasis. vol. 4 pp. 2230-2237 (2006).
Ni Heyu
Zhu Guangheng
Canadian Blood Services
Gambel Phillip
Jenkins Wilson Taylor & Hunt, P.A.
LandOfFree
Monoclonal antibodies against β 3 integrins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies against β 3 integrins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies against β 3 integrins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4177004